| Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial RS Kahn, WW Fleischhacker, H Boter, M Davidson, Y Vergouwe, ... The lancet 371 (9618), 1085-1097, 2008 | 1485 | 2008 |
| The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders I Pacchiarotti, DJ Bond, RJ Baldessarini, WA Nolen, H Grunze, RW Licht, ... American Journal of Psychiatry 170 (11), 1249-1262, 2013 | 770 | 2013 |
| Wilson disease A Członkowska, T Litwin, P Dusek, P Ferenci, S Lutsenko, V Medici, ... Nature reviews Disease primers 4 (1), 21, 2018 | 703 | 2018 |
| Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group DP Hibar, LT Westlye, NT Doan, N Jahanshad, JW Cheung, CRK Ching, ... Molecular psychiatry 23 (4), 932-942, 2018 | 688 | 2018 |
| Indicators of immune activation in major depression A Sluzewska, J Rybakowski, E Bosmans, M Sobieska, R Berghmans, ... Psychiatry research 64 (3), 161-167, 1996 | 520 | 1996 |
| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: acute and continuation treatment of … M Bauer, PC Whybrow, J Angst, M Versiani, HJ Möller, ... The World Journal of Biological Psychiatry 3 (1), 5-43, 2002 | 517 | 2002 |
| Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST) M Davidson, S Galderisi, M Weiser, N Werbeloff, WW Fleischhacker, ... American Journal of Psychiatry 166 (6), 675-682, 2009 | 452 | 2009 |
| Interleukin‐6 serum levels in depressed patients before and after treatment with fluoxetine A Służewska, JK Rybakowski, M Laciak, A Mackiewicz, M Sobieska, ... Annals of the New York Academy of Sciences 762 (1), 474-476, 1995 | 398 | 1995 |
| Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study L Hou, U Heilbronner, F Degenhardt, M Adli, K Akiyama, N Akula, ... The Lancet 387 (10023), 1085-1093, 2016 | 388 | 2016 |
| Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a … S Kasper, G Hajak, K Wulff, WJG Hoogendijk, AL Montejo, E Smeraldi, ... The Journal of clinical psychiatry 71 (2), 6060, 2010 | 382 | 2010 |
| Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar A Borkowska, JK Rybakowski Bipolar Disorders 3 (2), 88-94, 2001 | 311 | 2001 |
| Stratified medicine for mental disorders G Schumann, EB Binder, A Holte, ER de Kloet, KJ Oedegaard, ... European Neuropsychopharmacology 24 (1), 5-50, 2014 | 270 | 2014 |
| The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness JK Rybakowski, K Twardowska Journal of psychiatric research 33 (5), 363-370, 1999 | 260 | 1999 |
| Staging systems in bipolar disorder: an I nternational S ociety for B ipolar D isorders T ask F orce R eport F Kapczinski, PVS Magalhães, V Balanzá‐Martinez, VV Dias, S Frangou, ... Acta psychiatrica scandinavica 130 (5), 354-363, 2014 | 245 | 2014 |
| Polymorphism of the brain‐derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients JK Rybakowski, A Borkowska, PM Czerski, M Skibińska, J Hauser Bipolar disorders 5 (6), 468-472, 2003 | 240 | 2003 |
| Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder L Hou, SE Bergen, N Akula, J Song, CM Hultman, M Landén, M Adli, ... Human molecular genetics 25 (15), 3383-3394, 2016 | 224 | 2016 |
| Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: a systematic review B Misiak, B Stańczykiewicz, K Kotowicz, JK Rybakowski, J Samochowiec, ... Schizophrenia research 192, 16-29, 2018 | 198 | 2018 |
| Assessment of response to lithium maintenance treatment in bipolar disorder: a Consortium on Lithium Genetics (ConLiGen) report M Manchia, M Adli, N Akula, R Ardau, JM Aubry, L Backlund, ... PloS one 8 (6), e65636, 2013 | 184 | 2013 |
| Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study RS Kahn, IW van Rossum, S Leucht, P McGuire, SW Lewis, M Leboyer, ... The Lancet Psychiatry 5 (10), 797-807, 2018 | 180 | 2018 |
| Cross-cultural evaluation of two drinking assessment instruments: alcohol timeline followback and inventory of drinking situations LC Sobell, S Agrawal, H Annis, H Ayala-Velazquez, L Echeverria, GI Leo, ... Substance use & misuse 36 (3), 313-331, 2001 | 179 | 2001 |
